Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
J Allergy Clin Immunol Pract
; 10(8): 2099-2108.e6, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35487369
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Eosinophilia
/
Asthma
/
Biological Products
/
Anti-Asthmatic Agents
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
J Allergy Clin Immunol Pract
Year:
2022
Document type:
Article
Country of publication: